from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1447c/zwf2

LFCtreatmentdescriptionclass of inhibitor

-0.241

Amikacinug/mL Amikacintranslation

-1.570

Cap5-10ug/mL Capreomycintranslation

-1.957

Rox10-50 ug/mL Roxithromycintranslation

-0.400

SM2-5 ug/mL Streptomycintranslation

0.173

Tet5-10 ug/mL Tetracyclinetranslation

0.494

Rif0.2-5ug/mL Rifampicintranscription

-0.438

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.935

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.743

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.389

CPZ10-50 ug/mL Chlorpromazinerespiration

0.641

Clofazimine10-13 ug/mL Clofaziminerespiration

0.062

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.460

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.213

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.237

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.050

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.243

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.780

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.187

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.823

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.024

KCN5-20 ug/mL Potassium cyaniderespiration

-0.013

NaN30.2-2 mM Sodium aziderespiration

-0.637

Nigericin50 uM Nigericinrespiration

0.384

TRC10-150 ug/mL Triclosanrespiration

-0.793

TRZ10-25 ug/mL Thioridazinerespiration

-2.972

Valinomycin0.5-10 uM Valinomycinrespiration

0.568

ZnSO42 mM ZnSO4respiration

0.909

menadione6-10 ug/mL Menadionerespiration

0.500

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.089

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.123

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.101

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.203

NRP_1Non-replicating persistence stage 1dosRassociated

-0.014

Amp0.2mg/mL AmpicillincellWall

-0.134

Cephalexin20-100 ug/mL CephalexincellWall

-0.156

Cerulenin0.32-5 ug/mL CerulenincellWall

0.530

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.487

EMB10-20 ug/mL EthambutolcellWall

0.097

Eta12-40 ug/mL EthionamidecellWall

0.433

INH0.2-0.4 ug/mL IsoniazidcellWall

0.168

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.434

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.003

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.133

BZA0.12 mg/mL BenzamidearomaticAmides

-0.432

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.378

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.517

H2O24 mM hydrogen peroxideDNAdamaging

-0.434

Levo10 ug/mL LevofloxacinDNAdamaging

0.042

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.281

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.010

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.230

UVUV-irradiationDNAdamaging

-0.986

ARP41-4 ug/mL Antitubercular compound ARP4?

0.446

Antimycin12.5-50 ug/mL Antimycin A?

-0.499

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.031

PA_110-50 ug/mL Antitubercular compound PA-1?

0.533

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.230

PA8240.2-2 ug/mL PA-824?

-0.797

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.040

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.064

Verapamil50 uM Verapamil?

-0.066

mercaptoethanol2 mM 2-Mercaptoethanol?

0.019

methoxatin10-20 ug/mL Methoxatin?